Eduardo Tapia
Director of Life Science and Healthcare
DHL
/
View from the Top

Quality as Differentiator

Wed, 09/05/2018 - 11:08

Q: What are the main priorities that DHL has identified in Mexico’s healthcare sector?

A: Life Science and Healthcare in Mexico is one of the most important sectors for DHL Supply Chain as it represents one of the eight most important markets for the country. Mexico’s priorities for the sector are pharmaceutical laboratories, medical device companies and diagnostic laboratories. We have almost 100,000m2 dedicated exclusively to this sector, and half of this territory operates under a controlled temperature of 25°C. We have also developed networks with temperatures from 2-8 °C to ensure the integrity of our clients’ products, and have over 25 cold chambers all over the country. We have 30 distribution centers from which we can supply almost all hospitals within four hours. We are generating the appropriate infrastructure to address our client’s needs. For DHL Supply Chain, life sciences and healthcare is a continuous area of improvement because quality acts as our main differentiator.

Q: What is the main focus of DHL Supply Chain?

A: We are focusing mainly on medical devices and pharmaceutical products, but are also developing specialized solutions to improve hospital inventories. We have a wide range of specialized services for the healthcare sector which includes consulting services so that clients can develop their own supply networks, secondary packaging for retailers, complementary services and clinical trials delivery. Secondary packaging consists of a series of processes that include labeling and repackaging so that products can be shipped under the conditions determined by each company. This process can also be done under controlled-temperature conditions. We have the proper COFEPRIS licensing to do so.

Q: What role does technology play in logistics companies and how is DHL adapting?

A: Technology is becoming increasingly important to ensure safety. We have a solid tool for administering warehouse management systems (WMS) and another for transportation management systems (TMS) which enables us to provide versatile solutions with local teams.

Also, the digitalization has gained a lot of momentum in the region, and we are approaching some incubators to apply the good ideas that startups have regarding processes. Through this initiative, we are able to learn more about technology and IT, which allows us to improve our response to our client’s needs. We are also interested in using smart labels that incorporate radiofrequency identifiers (RFID) in hospitals to improve the inventory tracking. As technology is a fundamental part for the company, we have established an innovation center in Germany, where it takes place the solutions development for the industry.

Q: How is DHL growing alongside its clients and in what new areas is the company investing in Mexico?

A: We have both national and international clients and we are always willing to incorporate more. Our portfolio is comprised mainly of international companies, which has led to significant organic growth as these companies expand to other countries and bring their logistics operator.

Also, we have worked in the last two years to approach the health segment for animals, a well-developed area in other countries that we want to bring to Mexico. The underlying fundamentals of this sector are the same as for human health: ensuring temperature control, implementing best practices, traceability processes and properly administering the supply chain throughout the process.

Q: What are DHL Life Science and Healthcare’s main goals in Mexico?

A: Our goal is to generate success stories for our clients, while always prioritizing quality. In DHL’s strategy for 2020, healthcare and life sciences was named one of the most important sectors. We aim to continue growing organically in Mexico alongside our clients and focus on the improvement of our client’s distribution chains.